U.S. FDA approves first-ever long-acting HIV medication
The monthly injection treatment replaces the need for some to take daily pills. The company says the price of the injections is comparable to the cost of the pill versions.
Public health & disease
Psychedelic research center launched at New York’s Mount Sinai
Named the Center for Psychedelic Psychotherapy and Trauma Research the institution is first focusing on MDMA-assisted psychotherapy for PTSD.
Vast majority of countries worldwide have achieved social progress since 2011
Progress has been made globally on eight of 12 key indicators. The Gambia, Nepal, Sierra Leone, Ethiopia and Tunisia shown particularly notable improvement.
U.N. reclassifies cannabis as a less dangerous drug
Cannabis is no longer classified as a Schedule IV drug as per WHO’s recommendation. The declassification opens up the door for more research into its medicinal and therapeutic uses.
Phase 1 human trial for universal flu vaccine reports promising results
The Phase 1 trial, led by researchers from the Icahn School of Medicine at Mount Sinai, found this experimental vaccine to be both safe and effective at generating a long-term immune response in a small number of healthy adults.
First of-its-kind study suggests psilocybin can help treat migraines
A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks.
Elephantiasis cases cut by 150 million worldwide since 2000
Over the last 20 years, however, the number of people infected has dropped by 74%, from 199 million to 51.4 million, and last year three countries—Malawi, Kiribati, and Yemen—eliminated it altogether.
New HIV diagnoses in British gay and bisexual men hits 20-year-low
A new report shows that there were 1,700 new HIV diagnoses in gay and bisexual men in 2000. In 2019, new HIV diagnoses stood at 1,500. HIV transmission has fallen by 80% between 2011 when there was an estimated peak of 2,700 cases and 2019 when there was an estimated 540.
WHO rolls out plan to rid world of cervical cancer, saving millions of lives
The strategy involves vaccinating 90% of girls by the age of 15, screening 70% of women by the age of 35 and again by the age of 45, and treating 90% of women identified with cervical disease.
Promising flu vaccine derived from tobacco plant passes clinical trials
The recent development, promises to be a huge boost to the annual fight against the seasonal flu, as plants can be engineered to produce viral proteins and cultivated at scale.